Clinical Trial Update: Study of the Effect of Pneumococcal Conjugate Vaccine (PCV) on Immunogenicity of Pentacel™ [Phase 3]

View source ↗

Summary

Phase 3 study evaluating whether Pneumococcal Conjugate Vaccine (PCV) affects the immunogenicity of Pentacel; results were completed and posted in 2010.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diphtheria
• Haemophilus Influenzae Type Infection
• Pertussis
• Poliomyelitis
• Tetanus

Drugs mentioned

• Pentacel (DTaP-Hib-IPV vaccine)
• Pneumococcal conjugate vaccine (pneumococcal conjugate vaccine)

Snippet

Sponsor: Sanofi | Conditions: Diphtheria, Tetanus | Phase 3 | Status: COMPLETED | Results posted: 2010-02-12